1)Schmidt, Timo Torsten, et al. “Acute and subacute psychoactive effects of Kambô, the secretion of the Amazonian Giant Maki Frog (Phyllomedusa bicolor): retrospective reports.”
Scientific Reports 10.1 (2020).
2)Constantin, T. A. S. T. E. V. I. N. (1925). Le fleuve Muru. Ses habitants. Croyances et Moeurs Kachinaua. La Géographie, 43.
3)Erspamer, Vittorio, et al. “Pharmacological studies of ‘sapo’from the frog Phyllomedusa bicolor skin: a drug used by the Peruvian Matses Indians in shamanic hunting practices.” Toxicon 31.9 (1993).
4)Hesselink, JM Keppel, and Michael Winkelman. “Vaccination with Kambô against bad influences: Processes of symbolic healing and ecotherapy.” J Transpers Psychol 51 (2019).
5)Broccardo, M., et al. “Pharmacological data on dermorphins, a new class of potent opioid peptides from amphibian skin.” British journal of pharmacology 73.3 (1981).
6)Westphal, Manfred, R. Glenn Hammonds Jr, and Choh Hao Li. “Binding characteristics of dermorphin, and [dermorphin1–7]-βc-endorphin in rat brain membranes.” Peptides 6.1 (1985).
7)Stevens, Craig W., and Tony L. Yaksh. “Spinal action of dermorphin, an extremely potent opioid peptide from frog skin.” Brain research 385.2 (1986).
8)Puglisi-Allegra, Stefano, et al. “Behavioural data on dermorphins in mice.” European journal of pharmacology 82.3-4 (1982).
9)Basso, Nicola, et al. “Intrathecal dermorphine in postoperative analgesia.” Peptides 6 (1985).
10)Negri, Lucia, et al. “Dermorphin-related peptides from the skin of Phyllomedusa bicolor and their amidated analogs activate two mu opioid receptor subtypes that modulate antinociception and catalepsy in the rat.” Proceedings of the National Academy of Sciences 89.15 (1992).
11)Kreil, Gunther, et al. “Deltorphin, a novel amphibian skin peptide with high selectivity and affinity for δ opioid receptors.” European journal of pharmacology 162.1 (1989).
12)Erspamer, Vittorio, et al. “Deltorphins: a family of naturally occurring peptides with high affinity and selectivity for delta opioid binding sites.” Proceedings of the National Academy of Sciences 86.13 (1989).
13)Erspamer, V., et al. “Pharmacological actions of caerulein.” Experientia 23.9 (1967).
14)Anastasi, A., et al. “Structure and pharmacological actions of phyllocaerulein, a caerulein‐like nonapeptide: its occurrence in extracts of the skin of Phyllomedusa sauvagei and related Phyllomedusa species.” British journal of pharmacology 37.1 (1969).
15)Anastasi, A., G. Bertaccini, and V. Erspamer. “Pharmacological data on phyllokinin (bradykinyl-isoleucyl-tyrosine o-sulphate) and bradykinyl-isoleucyl-tyrosine.” British journal of pharmacology and chemotherapy 27.3 (1966).
16)Brown, Marvin R., et al. “Comparison of the biologic actions of corticotropin-releasing factor and sauvagine.” Regulatory peptides 4.2 (1982).
17)Lovejoy, David A., and Richard J. Balment. “Evolution and physiology of the corticotropin-releasing factor (CRF) family of neuropeptides in vertebrates.” General and comparative endocrinology 115.1 (1999).
18)Erspamer, V., et al. “Phyllomedusa skin: a huge factory and store-house of a variety of active peptides.” Peptides 6 (1985).
19)Broccardo, Maria, and Giovanna Improta. “Sauvagine-induced hypothermia: evidence for an interaction with the dopamminergic system.” European journal of pharmacology 258.3 (1994).
20)Moni, Roger W., Francisco S. Romero, and John W. Daly. “The amphiphilic peptide adenoregulin enhances agonist binding to A 1-adenosine receptors and [35 S] GTPγS to brain membranes.” Cellular and molecular neurobiology 15.4 (1995).
21)Mor, Amram, Mohamed Amiche, and Pierre Nicolas. “Structure, synthesis, and activity of dermaseptin b, a novel vertebrate defensive peptide from frog skin: relationship with adenoregulin.” Biochemistry 33.21 (1994).
22)Amiche, Mohamed, et al. “Precursors of vertebrate peptide antibiotics dermaseptin b and adenoregulin have extensive sequence identities with precursors of opioid peptides dermorphin, dermenkephalin, and deltorphins.” Journal of Biological Chemistry 269.27 (1994).
23)de Morais, Damila Rodrigues, et al. “Ayahuasca and Kambo intoxication after alternative natural therapy for depression, confirmed by mass spectrometry.” Forensic Toxicology 36.1 (2018).
24)Sung, Woo Sang, So Hyun Park, and Dong Gun Lee. “Antimicrobial effect and membrane-active mechanism of Urechistachykinins, neuropeptides derived from Urechis unicinctus.” FEBS letters 582.16 (2008).
25)van Zoggel, Hanneke, et al. “Antitumor and angiostatic activities of the antimicrobial peptide dermaseptin B2.” (2012).
26)Dos Santos, Célia, et al. “Studies of the antitumor mechanism of action of dermaseptin B2, a multifunctional cationic antimicrobial peptide, reveal a partial implication of cell surface glycosaminoglycans.” PLoS One 12.8 (2017).
27)Falconieri, G. Erspamer, A. Anastasi, and J. M. Cei. “Pharmacological observations on phyllomedusin.” Journal of Pharmacy and Pharmacology 22.6 (1970).
28)Kozawa, Hitoo, et al. “Isolation of four novel tachykinins from frog (Rana catesbeiana) brain and intestine.” Biochemical and biophysical research communications 177.1 (1991).
29)Erspamer, V., P. Melchiorri, and N. Sopranzi. “The action of bombesin on the systemic arterial blood pressure of some experimental animals.” British journal of pharmacology 45.3 (1972).
30)de Lima, Edilene Coffaci, and Beatriz Caiuby Labate. “” Remédio da Ciência” e” Remédio da Alma”: os usos da secreção do kambô (Phyllomedusa bicolor) nas cidades.” Campos-Revista de Antropologia 8.1 (2007).
31)ANVISA. Resolução-RE Nº8, de 29 de Abril de 2004. Agência Nacional de Vigilância Sanitária. Diário Oficial da União, Brasília, DF, Seção 1 Nº 82, p. 94, 2004 Apr 30
32)Hesselink, J. M. K. “Kambo and its Multitude of Biological Effects: Adverse Events or Pharmacological Effects.” Int Arch Clin Pharmacol 4 (2018).
33)Aquila, Isabella, et al. “The biological effects of Kambo: is there a relationship between its administration and sudden death?.” Journal of forensic sciences 63.3 (2018).
34)Menocchi, S. “Investigada morte de homem que tomou’vacina do sapo’.” Estadão (São Paulo) (2008).
35)Leban, Vid, Gordana Kozelj, and Miran Brvar. “The syndrome of inappropriate antidiuretic hormone secretion after giant leaf frog (Phyllomedusa bicolor) venom exposure.” Toxicon 120 (2016).
36)Yamashiro, Mari, et al. “A case of water intoxication with prolonged hyponatremia caused by excessive water drinking and secondary SIADH.” Case Reports in Nephrology and Dialysis 3.2 (2013).
37)Campodónico, Juan, et al. “Hiponatremia grave secundaria a la exposición a veneno de Phyllomedusa Bicolor (Rana Kambó). Caso clínico.” Revista médica de Chile 147.7 (2019).
38)Roy, Renitha, Aparna Baranwal, and Eduardo D. Espiridion. “Can overuse of Kambô cause psychosis?.” Cureus 10.6 (2018).
39)de la Vega, Mariana, Gilberto Maldonado, and Arnoldo Kraus. “Dermatomyositis induced by the secretion of Phyllomedusa bicolor or Kambô frog-A case report.” Toxicon 184 (2020).
40)Peleg Hasson, Shira, et al. “Kambô-Induced Systemic Inflammatory Response: A Case Report of Acute Disease Progression of Cholangiocarcinoma.” Integrative cancer therapies 20 (2021).
41)Pogorzelska, Joanna, and Tadeusz W. Łapiński. “Toxic hepatitis caused by the excretions of the Phyllomedusa bicolor frog–a case report.” Clinical and experimental hepatology 3.1 (2017).
42)Li, Kai, et al. “Prolonged toxicity from Kambo cleansing ritual.” Clinical Toxicology 56.11 (2018).
43)Kumachev, Alexander, et al. “Poisoning from the Kambô ritual.” Canadian journal of emergency medicine 20.6 (2018).
44)Gonzaga, Ernesto S. Robalino, et al. “Kambo frog poison as a cause of esophageal rupture.” Cureus 12.9 (2020).
Recensioni
Ancora non ci sono recensioni.